Crosscope and BALCO Medical Centre have joined hands for the digital transformation of their pathology department.
This collaboration will focus on using an AI-enabled Digital Pathology Platform from Crosscope, thereby, transforming analog histopathology workflow to AI-enabled digital workflow for the hospital.
“Effective deployment of Artificial Intelligence (AI) is the need of the hour in the healthcare sector. We anticipate digitization of pathology will result in improved workflow and most importantly, result in rapid and accurate diagnosis. These technological developments will enable faster, efficient, and affordable cancer care solutions for all”, said Chairperson of BALCO Medical Centre, Jyoti Agarwal.
“Indian healthcare is on the cusp of digital transformation and we, at Crosscope, are enabling healthcare providers with AI-assisted remote workflows for a pathology revolution. Our ultimate vision is to aid healthcare organizations with reduced turnaround time, improved diagnostic performance, global collaborations, and provide consistent and accurate care to patients on time” said Jayendra Shinde, Ph.D., the CEO of Crosscope.
“Microscopic examination of biopsies remains a daunting task and is the gold standard for diagnosis and staging of cancer. This type of AI-based solution platform, like Crosscope, is expected to lead to diagnostic and therapeutic precision and shorten the period between primary diagnosis and therapy”, said Sandeep Ojha, Consultant, Histopathology, BALCO Medical Centre.
“Digital transformation is a reality today and the effects of which can be seen in Crosscope’s AI-enabled vendor-agnostic Digital Pathology platform, which will allow a seamless transition from analog to digital with tools like AI-assisted triaging for efficient histopathology workload management and an integrated workflow solution that incorporates AI-assisted cancer detection tools for several tumor types ultimately assisting pathologists, cancer care providers in the region and around the world in early detection paving the way for precision medicine & early detection,” said Puneet Pantane, Chief Business Officer at Crosscope.
With new cancer cases projected to rise by 70% within the next couple of decades, Crosscope is building a suite of technology solutions to usher innovation through cancer data-driven healthcare for accelerated and accurate cancer diagnosis for better patient outcomes.
Crosscope, known for its expertise in deep learning-based computational pathology algorithms, will implement its AI-enabled Digital Pathology platform Crosscope Dx, which provides a unified solution for the needs at BALCO Medical Centre.
This partnership will lead to the deployment of Crosscope’s Digital Pathology platform to provide AI-based diagnostics support ensuring precision-based, time-bound cancer diagnosis, support collaboration, pathology workflows, and archiving of pathology images.